WO2001040446A1 - Pour-on formulations - Google Patents

Pour-on formulations Download PDF

Info

Publication number
WO2001040446A1
WO2001040446A1 PCT/US2000/030143 US0030143W WO0140446A1 WO 2001040446 A1 WO2001040446 A1 WO 2001040446A1 US 0030143 W US0030143 W US 0030143W WO 0140446 A1 WO0140446 A1 WO 0140446A1
Authority
WO
WIPO (PCT)
Prior art keywords
sep
carrier
formulation
alcohol
ipm
Prior art date
Application number
PCT/US2000/030143
Other languages
French (fr)
Other versions
WO2001040446A3 (en
WO2001040446A8 (en
Inventor
Kristina Clare Hacket
Lionel Barry Lowe
James Terence Rothwell
Original Assignee
Lilly Co Eli
Kristina Clare Hacket
Lionel Barry Lowe
James Terence Rothwell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Kristina Clare Hacket, Lionel Barry Lowe, James Terence Rothwell filed Critical Lilly Co Eli
Priority to AU19148/01A priority Critical patent/AU775911B2/en
Priority to DK00982076T priority patent/DK1237408T3/en
Priority to DE60008422T priority patent/DE60008422T2/en
Priority to EP00982076A priority patent/EP1237408B1/en
Priority to AT00982076T priority patent/ATE259590T1/en
Priority to US10/130,315 priority patent/US6955818B1/en
Priority to NZ518030A priority patent/NZ518030A/en
Publication of WO2001040446A1 publication Critical patent/WO2001040446A1/en
Publication of WO2001040446A8 publication Critical patent/WO2001040446A8/en
Publication of WO2001040446A3 publication Critical patent/WO2001040446A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/32Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

A non-irritant topically acceptable carrier selected from the group consisting of: a) i) at least one of tripropylene glycol methyl ether and dipropylene glycol methyl ether, and ii) at least one of alcohol, wool grease and propylene glycol, wherein (i) is present in an amount of at least about 60% wt of the carrier; b) i) at least one of octyl palmitate, octyl stearate and glyceryl tri caprylate/caprate, and ii) at least one of dioctyl succinate, isopropyl myristate, cetearyl octanoate, propylene glycol 2 myristyl ether propionate, isopropyl palmitate, isopropyl laurate, isocetyl stearate, oleic acid and methyl oleate, and optionally including iii) at least one of alcohol, wool grease and propylene glycol, wherein (ii) is present in an amount of up to about 40% wt of the carrier; and c) i) at least one of octyl palmitate, octyl stearate and glyceryl tri caprylate/caprate, and ii) at least one of alcohol, wool grease and propylene glycol, wherein (i) is present in an amount of at least about 60% wt of the carrier.

Description


  



   POUR-ON FORMULATIONS
 The present invention relates to non-irritant carriers or carrier blends suitable for use in pour-on formulations, the formulations themselves and to the use of those pour-on formulations in the control of external parasites in animals of agricultural worth including sheep, cattle, pigs, goats, camelids, horses and other small ruminants.



   Animals of agricultural worth, such as sheep, cattle, horses, goats, pigs, other ruminants and camelids, are almost invariably subject to the activity of ectoparasites such as flies, ticks, lice and fleas. Such external parasites irritate the animals and can cause economic losses in the forms of poor quality hide, wool or sheep skin, reduced weight gain and even death as a result of the animal carrying harmful parasites.



   It has long been common practice to control external parasites on sheep, cattle and other animals including goats, pigs and horses by the localised topical application of a pour-on formulation containing an active insecticide/parasiticide and a carrier/vehicle. A pour-on formulation is typically liquid and is usually applied to the exterior of an animal as a line or a spot, which then acts to protect the external surface of the animal against external parasites such as lice, keds, mites, ticks and flies.



   Ideally, when the formulation is applied topically to a localised area, the ectoparasiticide migrates over the surface of the animal to protect its whole external surface area.



   The carrier (also referred to herein as vehicle') present in such pour-on formulations is formulated to achieve good spread around the skin and/or penetration of the epidermis of the animal. To date, commercial pour-on formulations are suspensions, emulsifiable concentrates or solutions and are often comprised of at least one organic solvent. Solvents commonly used as carriers in such pour-on formulations include propylene glycol, paraffins, isoparaffins, aromatics, isopropyl myristate (IPM), glycol ethers, and alcohols such as n-propyl alcohol. U. S. Patent
No. 4, 672, 072 discloses a non-aqueous carrier comprising one or more organic solvents such as xylene, toluene, cyclohexanone and a glycol-such as ethylene glycol, polyethylene glycols, polypropylene glycols, propylene glycol, ethylene glycol-propylene glycol copolymers and alkyl ethers thereof.

   A preferred solvent system disclosed in U. S. Patent No. 4, 672, 072 comprises 30-70 wt% xylene, 2040 wt% cyclohexanone and 5-25 wt% vegetable oil. U. S.



  Patent No. 5, 045, 536 discloses a pour-on formulation in which the solvent system comprises   80-98%    w/v of a nonvolatile oil and   2-20%    w/v of a volatile silicone.



   Unfortunately, the solvent systems utilised as carriers/vehicles in commercially available pour-on formulations may result in some form of tissue reaction which leads to discomfort to the animal and in many cases, damage to the hide, sheepskin or fleece and resultant economic loss. In particular, some breeds of sheep such as the Merino have very sensitive skins which react to the solvent systems in some commercially available pour-on formulations. For example, aromatics such as xylene and the paraffins produce tissue reactions such as dryness, redness and cracking of the skin.



   U. K. Patent GB 2 110 091 B attempts to address the problems of skin reactions in sheep treated with pour-on formulations by formulating a composition in which the carrier/vehicle comprises a first solvent selected from the group consisting of alkoxylated   C1-C4    alcohols and a second solvent selected from the group consisting of di (Cl-C6 alkyl) esters of   C2-C6    dicarboxylic acids or   C2-C6    dihydric alcohols and   C2-C6    carboxylate esters of alcohol alkoxylates. However, sensitive animal hide can still react adversely to such formulations.



   Similarly, European Patent Publication No. 0 120 286 B1 addresses the irritancy or toxicity caused to animals by solvent systems in pour-on formulations by providing an active ectoparasiticide in a glycol or glycerol ester of a   C8-Clo    fatty acid. However, such oil-based formulations can still cause adverse epidermal reactions in animals topically treated with such formulations.



   European Patent Publication No. 0 137 627 B1 discloses a pour-on formulation in which the active is an endoparasticide and the carrier comprises at least one saturated aliphatic ester of a mono alkyl ether of a monoor poly-alkylene glycol such as   1-ethoxyprop-2-yl    acetate and   2- (n-butoxy)    ethyl butyrate. While the specification claims that such formulations are free from adverse skin reaction in treated sheep or cattle, it is noted that adverse epidermal reactions can still be observed, particularly in sheep with sensitive skin.



   Accordingly, prior art pour-on formulations-even those promoted as non-irritant--have been found by the present inventors to cause pain and hide damage, and fleece damage in the case of sheep or other fleece bearing animals. Such formulations cause skin damage especially in sheep, which have very thin skin and are acutely susceptible to chemical skin damage.



   Additionally, with conventional pour-on formulations   95-98%    of the applied active ingredient remains at the site of application bound to the animal's fleece or hair, which results in a lack of efficacy. 



   This invention provides non-toxic and non-irritant carriers that can be used to prepare improved pour-on ectoparasiticidal formulations. The invention also provides these improved formulations, which are especially beneficial because they can be topically applied to animals of agricultural worth to control ectoparasites without causing adverse epidermal reaction in the animals. The invention also provides a method of controlling ectoparasites in an animal of agricultural worth by topically applying one of these non-irritant pour-on ectoparasiticidal formulations on the animal.



   The word carrier'is used throughout the present specification to include carrier blends, that is mixtures of more than one substance.



   The   term"controlling"as    used in this specification refers to preventing, ameliorating or eradicating the target ectoparasite.



   Certain acronyms and abbreviations used throughout this specification are commonly used in this art and have the following meanings :
 The   term"Alcohol"refers    to benzyl alcohol, propyl alcohol, diacetone alcohol or other suitable alcohol ;
 COI is a blend of isopropyl myristate and cetearyl octanoate, which are branched chain esters ; it acts as an emollient and spreading agent ;
 DB is diethylene glycol n-butyl ether ;
 DPM is dipropylene glycol methyl ether ;
 GTCC is glyceryl tri caprylate/caprate, which is an excellent carrier or vehicle for active agents ;
 ICS is isocetyl stearate, which can be used as an emollient, lubricant and spreading agent ;
 IPM is isopropyl myristate, which has excellent spreading and emollient properties ;
 IPL is isopropyl laurate ;

   
 IPP is isopropyl palmitate ;
 OP is octyl palmitate or 2-ethylhexyl palmitate, which is an excellent lubricant ;
 OS is octyl stearate or 2-ethylhexyl stearate, which is also a lubricant ;
 OSU is dioctyl succinate or di-2-ethylhexyl succinate, which promotes wetting and spreading of lipophilic substances onto the skin ;
 PG is propylene glycol ;
 PMP is, which spreads rapidly and promotes wetting of other material ;
 SC is a suspension concentrate ;
 TPM is tripropylene glycol methyl ether ; and
 WG is wool grease.



   In a first aspect, the invention provides a nonirritant topically acceptable carrier selected from the group consisting of :
 a) i) at least one of TPM and DPM, and
 ii) at least one of alcohol, WG and PG,
 wherein (i) is present in an amount of at least about   60%    wt of the carrier ;
 b) i) at least one of OP, OS and GTCC, and
 ii) at least one of OSU, IPM, COI, PMP, IPP,
IPL, ICS, oleic acid and methyl oleate, and optionally including
 iii) at least one of alcohol, WG and PG,
 wherein (ii) is present in an amount of up to about 40% wt of the carrier ; and
 c) i) at least one of OP, OS and GTCC, and
 ii) at least one of alcohol, WG and PG,
 wherein (i) is present in an amount of at least about   60%    wt of the carrier.



   In a second aspect, the invention provides a nonirritant pour-on formulation for controlling an external parasite in an animal of agricultural worth, said formulation including an ectoparasiticidal amount of an active agent and a topically acceptable carrier of the first aspect of the invention.



   A third aspect of this invention provides a method of controlling an external parasite in an animal of agricultural worth, said method including topically applying an ectoparasiticidally effective volume of a pour-on formulation according to the second aspect of the invention to a localised area of the external surface of the animal.



   Another aspect of this invention relates to the use of a carrier of the first aspect in a non-irritant pouron formulation for controlling an external parasite in an animal of agricultural worth wherein the formulation also includes an effective amount of an ectoparasiticidal agent.



   The invention is predicated upon a novel approach to developing carriers suitable for use in non-irritant and non-toxic pour-on formulations that are to be used for animals of agricultural worth, such as sheep, cattle, horses, goats and pigs. This approach involved determining the effects of a potential pour-on ingredient on the skin using a histopathological methodology rather than relying on clinical observation. Such a histopathological approach has resulted in the significantly improved pour-on formulations of this invention.



   The carriers of the first aspect of this invention have several advantages. They are non-irritant and effective. They also have a satisfactory freezing point, suitable viscosity and are cost effective. They easily dissolve any active agent, are easy to use and provide superior operator safety.



   The formulations prepared using these carriers (or vehicles) represent a great advance over currently available pour-on formulations which have been developed upon an ad hoc basis. Such a histopathological approach has allowed for the identification and elimination of ingredients (including those used in current pour-on formulations) that cause skin/hide damage on a pathological level and also has allowed for the accurate determination of what percentage of an irritant ingredient will not cause damage.



   Further, the carriers and formulations of this invention promote the spread of active agent around the body and hence increase efficacy against ectoparasites which can be present on any part of the body.



   Finally, the formulations of this invention require the presence of less active agent, thereby reducing wool and tissue residues and environmental contamination.



   One preferred embodiment of the first aspect of this invention is a non-irritant, topically acceptable carrier selected from the group consisting of :
 a) i) at least one of TPM and DPM, and
 ii) at least one of alcohol, WG and PG,
 wherein (i) is present in an amount of at least about   60%    wt of the carrier ; and
 b) i) at least one of OP, OS and GTCC, and
 ii) at least one of OSU, IPM, COI, PMP, IPP,
IPL, ICS, oleic acid and methyl oleate,
 wherein (ii) is present in an amount of up to about   40%    wt of the carrier.



   In carrier (a), solvent (i) is typically present in an amount of at least about   70%    wt of the carrier.



   When (a) (ii) is an alcohol, it is typically benzyl alcohol or diacetone alcohol.



   An example of carrier (a) is TPM/alcohol where
TPM is present in an amount of at least about 60   %    wt of the carrier. A particularly suitable TPM/alcohol carrier is
TPM/benzyl alcohol. Typically, a TPM/alcohol carrier is formulated having a TPM : alcohol ratio in the range of 6095 : 40-5, and more typically 80 : 20.



   In carrier (b), substance (ii) is typically present in an amount of up to about 30   %    wt of the carrier.



   Examples of carrier (b) are : OP or OS/IPM/OSU where the combined amount of IPM and OSU is up to about 40% wt of the carrier ; and GTCC/IPM/COI where the combined amount of IPM and COI is up to about   40%    wt of the carrier.



  When the carrier is OP/IPM/OSU, the preferred ratio is a range of OP : IPM : OSU of 60-90 : 20-5 : 20-5, most preferably 70 : 15 : 15. When the carrier is a combination of
GTCC/IPM/COI, the preferred ratio of GTCC : IPM : COI is in a range of 60-90 : 20-5 : 20-5, preferably 70 : 15 : 15.



   Optionally, carrier (b) can include : iii) at least one of alcohol, WG and PG.



   One embodiment of the second aspect of the invention, i. e., a pour-on formulation for control of an external parasite in an animal of agricultural worth, is a formulation that includes :
 (a) from 0. 1 to   40%    by weight of at least one active agent selected from the group consisting of synthetic pyrethroids, organophosphates, macrocyclic lactones (avermectins/milbemycins), benzoylphenylureas (and other insect growth regulators) and spinosyns ; and
 (b) from 60-99.   9%    by weight of a carrier of the first aspect of the invention.



   More specifically, this embodiment provides a pour-on formulation for control of an external parasite in an animal of agricultural worth, said formulation including :
 (a) from 0. 1 to 40% by weight of at least one active agent selected from the group consisting of synthetic pyrethroids, organophosphates, macrocyclic lactones (avermectins/milbemycins), benzoylphenylureas (and other insect growth regulators) and spinosyns ; and 
 (b) from 60-99.   9%    by weight of a carrier selected from the group consisting of (1) TPM/alcohol, wherein the
TPM is present in an amount of at least   60%    by weight of the carrier ;

   (2) OP/IPM/OSU wherein the combined amount of
IPM/OSU is at least   40%    by weight of the carrier ; and (3)   GTCC/IPM/COI    wherein the combined amount of IPM/COI is at least 40% by weight of the carrier.



   The pour-on formulations of this invention can be in the form of a liquid, powder, emulsion, foam, paste, aerosol, ointment, salve or gel. Typically, the pour-on formulation is liquid.



   These pour-on formulations can be effectively applied to sheep, cattle, goats, other ruminants, camelids, pigs and horses. The formulations are particularly suitable to be applied to sheep, especially short wool sheep.



   The pour-on formulations are applied locally to the external surface of an animal. Although they can be applied at any time, certain regimens are preferable. For example, when the formulations are applied to sheep, they are typically applied within 24 hours after shearing. The sheep are then usually treated each year after shearing.



  Fibre animals such as goats and camelids are also treated after shearing. Cattle are treated depending on the pest concerned, such as in autumn/winter for lice and in summer for flies.



   The pour-on formulation is typically applied by pouring in one or several lines or in a spot on the dorsal midline (back) or shoulder of an animal. More typically, the formulation is applied by pouring it along the back of the animal, following the spine. The formulation can also be applied to the animal by other conventional methods, including wiping an impregnated material over at least a small area of the animal, or applying it using a commercially available applicator, by means of a syringe, by spraying or by using a spray race.



   An effective amount of the pour-on formulation for topical application will depend on several factors, e. g. the animal being treated, the active agent in the formulation, and the specific formulation being used. Generally, the formulation should provide about 0. 1-2000 mg of the active agent/kg of animal body weight.



   The effective amount of formulation will vary depending on the animal being treated. For example, when the formulation is to be applied to a cow, it should provide about 100-2000 mg of the active agent. When it is to be applied to a sheep, it should provide about 20-1000 mg of the active agent.



   The effective amount of active (ectoparasiticidal) agent in the formulation will depend on both the agent and the carrier. Examples of preferred amounts of active agents (per kg of animal body weight) are : about 300 mg of spinosad or 100 mg of ivermectin or 600 mg of benzoylphenylurea or 80 mg of zeta-cypermethrin, when these agents are formulated in OP/IPM/OSU or TPM/alcohol or
GTCC/IPM/COI.



   A pour-on formulation of this invention is generally formulated such that the active agent is present in a concentration of about 0.   1-20%    weight/volume, preferably about 0. 5 to   5%,    depending on the potency of the active agent. Typically, the formulation will contain one or more of the preferred active agents in the following concentrations (weight/volume) :
 zeta-cypermethrin : about 0. 5% ;
 ivermectin : about 0.   6% ;   
 hexaflumuron : about   4-5%    ; and
 spinosad : about   2%.    



   Typically, only a small volume of the pour-on formulation, such as in the order of 1-80 mL, is required in order to be effective against the external parasites. For larger animals such as cattle, a volume of 10-60 mL is preferred ; and for smaller animals such as sheep, a volume of 5-20 mL is suitable.



   In the pour-on formulations of this invention, the active/ectoparasiticidal agent can be a single   insecticidal/ectoparasiticidal    compound or a combination of two or more insecticidal/ectoparasiticidal compounds. The active agent is typically selected from the group consisting of spinosyns, synthetic pyrethroids, macrocyclic lactones, diamidides (formamidines) such as amitraz, thiazoles, dursban, carbamates, benzimidazoles, fipronil, imidacloprid, triazines, water-insoluble organo-phosphate compounds, propoxur, cabaryl, maldison, dimethoate, rotenone, piperonyl butoxide, Bacillus thuringensis, ronnel, crufomate, benzoylphenylureas and other insect growth regulators (IGR) such as hexaflumuron or insect development inhibitors (IDI), or related juvenile insect hormone analogues, including cyromazine and dicyclanil.



   A particularly useful spinosyn is spinosad.



   Examples of synthetic pyrethoids are cyhalothrin, bioresmethrin, bifenthrin, pyrethrins, permethrin, biopermethrin, phenothrin, alphamethrin, barthrin, deltamethrin, phthalthrin, cypermethrin, dimethrin, flumethrin, resmethrin, fluvalinate, allethrin, cismethrin, cyfluthrin, indothrin, cyphenothrin, cyclethrin, tetramethrin, tralomethrin, sumithrin, tralocythrin, fenpropanate and fenvalerate. Particularly useful pyrethrins are alpha-cypermethrin and zeta-cypermethrin.



   Examples of macrocyclic lactones are ivermectin, abamectin, moxidectin, doramectin, eprinomectin, and milbemycin. 



   Examples of water-insoluble organo-phosphate compounds are tetrachlovinphos, chlorpyriphos methyl, pyrimiphos methyl, chlorpyriphos, diazinon, trichlorphos,   fenchlorphos,    coumaphos, crotoxyphos, chlofenvinephos, dichlofenvinphos, dichlorfenthion, quinthiophos, propetamphos, famphur, bromophos ethyl, ethion, and dioxathion.



   Examples of benzoylphenylureas are lufenuron, diflubenzuron, triflumuron and fluazuron.



   More typically, the active agent is selected from the group consisting of spinosad, zeta-cypermethrin, ivermectin and hexaflumuron.



   The carriers of this invention are non-aqueous.



  The active agent is suspended, dissolved or dispersed in the carrier. The carrier promotes the penetration of the active agent through the animal's coat and spread of the agent over the skin.



   In addition to the carrier and the active agent, the pour-on formulations of this invention can also include one or more additional ingredients. Examples of suitable additional ingredients are stabilizers such as antioxidants, spreading agents, preservatives, adhesion promoters, active solubilisers such as oleic acid, viscosity modifiers, UV blockers or absorbers, and colourants. Surface active agents, including anionic, cationic, non-ionic and ampholytic surface active agents, can also be included in these formulations.



   The formulations of this invention typically include an antioxidant, such as BHT (butylated hydroxytoluene). The antioxidant is generally present in amounts of at 0.   1-5%    (wt/vol).



   Some of the formulations require a solubilizer, such as oleic acid, to dissolve the active agent, particularly if spinosad is used. 



   Common spreading agents used in these pour-on formulations are : IPM, IPP, caprylic/capric acid esters of saturated   C12-Cl8    fatty alcohols, oleic acid, oleyl ester, ethyl oleate, triglycerides, silicone oils and DPM.



   The pour-on formulations of this invention are prepared according to known techniques. Where the pour-on is a solution, the parasiticide/insecticide is mixed with the carrier or vehicle, using heat and stirring where required. Auxiliary or additional ingredients can be added to the mixture of active agent and carrier, or they can be mixed with the active agent prior to the addition of the carrier. If the pour-on is an emulsion or suspension, these formulations are similarly prepared using known techniques.



   A general procedure for preparing these formulations involves these steps :
 1) Weigh out the desired weight of technical active agent ;
 2) Add 0.   1-1%    w/v BHT or other appropriate antioxidant ;
 3) If the agent is spinosad, add oleic acid (4 times the weight of spinosad used), and dissolve by stirring ;
 4) Make up the desired volume by adding a carrier of this invention ;
 5) Mix by stirring and gently heating if necessary-to up to 50 degrees C ; and
 6) Dispense into impervious containers and protect from light.



   This invention further provides a method of controlling an external parasite in an animal of agricultural worth, said method including topically applying an ectoparasiticidally effective volume of a pour-on formulation according to the second aspect of the invention to a localised area of the external surface of the animal. 



  The target external parasites include lice, ticks, mites, biting flies, carnivorous flies and fleas. Animals of agricultural worth include cattle, sheep, goats, pigs, horses, camelids and other ruminants.



   More specifically, the method of this invention can be used
 on sheep : to control ked (Melophagus ovinus), chewing louse (Bovicola ovis), sucking louse (Linognatus   pedalis,    L.   africanus,    L. stenopsis), sheep scab mite   (Psoroptes    ovis), itch mite   (Psorergates    ovis), mange mite (Chorioptes ovis), screw worms (Cochliomyia   spp.,      Chrysomya    sp.,   Wohlfahrtia    spp.), ticks (Boophilus spp., Ixodes spp.,   Haemophysalis    spp., Ambylomma spp., Dermacentor   spp.,   
Hyalomma   spp.,    Rhipicephalus spp.), nasal bot flies (Oestrus ovis) and blowflies (Lucilia, Calliphora, Phormia,
Protophormia spp.)   ;   
 on goats :

   to control chewing louse (Bovicola limbata, B. crassiceps, B. caprae) and sucking louse species (Linognathus spp.) ;
 on camelids : to control chewing lice (Bovicola breviceps) ;
 on cattle : to control sucking louse (Linognathus vituli, Haematopinus eurysternus, Solenopotes capillatus) and chewing louse (Bovicola bovis), flies (e. g., Musca domestica, Haematobia irritas, Stomoxys   calcitrans),    screw worms (Chrysomya bezziana,   Cochliomyia    hominivorax), midges, mosquitos, mites (Chorioptes bovis, Sarcoptes bovis,
Psorpotes ovis, Demodex bovis), and ticks (Boophilus spp,
Ixodes spp, Haemophysalis spp, Amblyomma spp, Dermacentor spp.   Hyalomma    spp, Rhipicephalus spp, Otobius megnini) ;
 on horses :

   to control ticks, mites (Chorioptes equi, Psoroptes equi, Sarcoptes equi, Demodex   equi),    chewing and sucking lice (Bovicola equi, Haematopinus asini), fleas, 
Dipteran species (Culicoides spp, Simulium spp and other flies) ; and
 on pigs : to control ticks, mites (including
Sarcoptes suis, Demodex suis), lice (Haematopinus   spp),    fleas and Dipteran fly species.



   The formulation is applied to the dorsal midline of the animal, from the poll to the base of the tail.



  Preferably, the formulation is applied using an applicator, usually a self-filling dosing gun with a nozzle to dispense a narrow or wide band or lines of formulation along the back. The formulation is applied at 0. 2 to 1 mL per kilogram of body weight or unit of surface area.



  Alternatively, a set volume is applied to each bodyweight class, e. g., 10 mL for sheep or animals less than 30 kg, 15 mL for animals weighing 31-50 kg, and 20 mL for animals weighing 51+ kg. In larger animals, for example in cattle, a typical volume would be 30 mL for animals less than 250 kg, 45 mL for animals weighing 250 to 400 kg and 60   mL    for animals of 400+ kg in weight. The formulation can also be applied from other containers or vessels as required.



   Sheep and other fibre producing animals should be treated within 24 hours after shearing or fibre collection.



  Cattle, horses and other animals should be treated so as to ensure maximum impact on the pest to be controlled. For example, cattle should be treated for lice control in autumn and/or winter. Nuisance or biting fly treatment is applied when flies begin to cause irritation. This invention is illustrated in a non-limiting manner by reference to the following Examples.



  Example 1 : Pour-on carrier/vehicle sheep skin irritation studies
 Studies were conducted to investigate and characterise the changes occurring in Merino sheep skin following the application of a range of candidate pour-on formulation components in order to discern safe carriers.



  Chemicals, emollients, wool grease derivatives and a wide range of formulations were applied (in 1 mL volumes) to each of 18 sites on the back and flanks of 15 recently shorn
Merino sheep.



   In the first study, skin samples were collected at necropsy 3   k    weeks after application. In subsequent studies, skin samples were collected 2 weeks after application. Standard haematoxylin and eosin stained sections were prepared from each piece of treated skin. A histological scoring system was devised to allow comparison of treatments. Each skin was assessed for the degree of hyperkeratosis, acanthosis and inflammatory cell infiltrate of the superficial dermis and given a rating score from 015. A score of 0 = no change through to a score of 15 for very severe damage. Normal skin scored 2-4,  >  4 was abnormal and  >  7 was very abnormal. Treatments yielding a score   $r 4. 5    were considered safe.



   Table 1 summarizes the results of these studies.



  Table 1. Mean skin irritation scores
EMI16.1     


<tb> Chemical <SEP> Score
<tb> PMP <SEP> 9
<tb> cetearyl <SEP> octanoate <SEP> 4. <SEP> 3
<tb> IPM <SEP> 8
<tb> OP <SEP> 3. <SEP> 3
<tb> OSU <SEP> 4. <SEP> 8
<tb> GTCC <SEP> 2
<tb> lanolin <SEP> oil/IPM <SEP> 7. <SEP> 5
<tb> (80 <SEP> : <SEP> 20)
<tb> GTCC/IPM <SEP> (80 <SEP> : <SEP> 20) <SEP> 2. <SEP> 5
<tb> OP/IPM <SEP> (80 <SEP> : <SEP> 20) <SEP> 2. <SEP> 5
<tb> GTCC/COI <SEP> (80:20) <SEP> 3
<tb>  
EMI17.1     


OP/OSU <SEP> (80 <SEP> : <SEP> 20) <SEP> 4. <SEP> 5
<tb> DB <SEP> 7
<tb> DPM <SEP> 4
<tb> TPM <SEP> 3
<tb> Diacetone <SEP> alcohol <SEP> 2
<tb> TPM/diacetone <SEP> alcohol <SEP> 2. <SEP> 5
<tb> (80 <SEP> : <SEP> 20)
<tb> OP/IPM/OSU <SEP> (70 <SEP> : <SEP> 15 <SEP> : <SEP> 15) <SEP> 3. <SEP> 2
<tb> TPM/benzyl <SEP> alcohol <SEP> 2. <SEP> 7
<tb> (80 <SEP> :

   <SEP> 20)
<tb> untreated <SEP> 2. <SEP> 5
<tb> 
 A small experiment was conducted to investigate the pathology over time following application of IPM. It was applied to 2 separate sites on 1 sheep on   1,    2, 4, 7, 10 and 14 days before slaughter.



   These studies showed that, despite careful daily observation of the skin, some chemicals caused severe histological dermatitis in the absence of grossly observable changes. IPM caused severe dermatitis. Adding small percentages of other emollients or wool grease failed to make IPM non-irritant. Reducing the IPM percentage to 20% could yield a non-irritant formulation as long as the other components were non-irritant. Several other excipients were also highly irritant-such as PMP,   C8-C10    methyl esters, methyl oleate, DB, 2-octyl-dodecanol and propylene glycol dicaprylate dicaprate. Other excipients and mixtures of excipients caused mild to moderate dermatitis-such as cetearyl octanoate, DPM, propoxy 15 stearyl alcohol, ICS and
OSU.

   Some mixtures were non-irritant-such as OP/IPM (80 : 20) ; GTCC/OP (80 : 20) ; OP/IPM/OSU (70 : 15 : 15) ;
GTCC/IPM/COI (70 : 15 : 15) ; TPM/benzyl alcohol (80 : 20) and several mixtures incorporating wool grease derivatives. 



  GTCC, OP, diacetone alcohol, liquid wool grease, lanolin oil, and TPM were non-irritant.



   A commercial formulation of deltamethrin in cyclohexane caused moderate dermatitis. This formulation was reported to cause scab formation on the skin, leading to damage detectable in tanned wool skins (Britt, Cotton, Trask and Pitman, 1984, Aust vet   J,    61, 329-330). The pathology described in that paper was similar in type and pattern to that seen associated with the same formulation in these studies, but was milder than the severe dermatitis associated with several vehicles investigated in these studies.



   Examples 2-11 describe In vivo formulation comparison and efficacy studies.



   Trials were conducted to assess the comparative efficiency of certain pour-on formulations of this invention and commercially available pour-on formulations in the control of external parasites in sheep.



   Example 2 : Evaluation of wool grease formulations
 and IPM for the control of Bovicola ovis
 using zeta-cypermethrin and spinosad.



   The purposes of this study were to evaluate wool grease as a formulation to deliver spinosad, to determine the dose required to kill   100%    of lice in sheep and to evaluate the suitability of the formulation to deliver zetacypermethrin, compared with an isopropyl myristate (IPM) formulation.



   Sheep were heavily infested with the highly synthetic pyrethroid (SP) resistant, Hartley strain of lice.



  Sheep were shorn, lice counted and sheep allocated to ten groups of six sheep, each divided into three groups of two per treatment. All sheep were treated at the rate of 2 mL of test formulation/10 kg of body weight. Treatments were, respectively : wool grease only ; 2 mg/kg deltamethrin and 4 mg/kg alphacypermethrin in commercial formulations ; spinosad in wool grease at 0. 08 mg/kg, 0. 4 mg/kg, 2 mg/kg and 10 mg/kg ; zeta-cypermethrin in wool grease at 0. 66 mg/kg and 2 mg/kg ; and spinosad in IPM at 0. 4 mg/kg. Lice numbers were counted weekly for eight weeks.



   At eight weeks : 2 mg/kg deltamethrin gave   8%    efficacy ; 4 mg/kg alphacypermethrin gave 9% efficacy ; 0. 66 mg/kg zeta-cypermethrin gave 0% efficiacy ; 2 mg/kg zetacypermethrin gave 43% efficiacy ; 0. 08, 0. 4, 2 and 10 mg/kg spinosad in wool grease gave   42%,      54%,    98% and 99.   9%    efficacy, respectively ; and 0. 4 mg/kg spinosad in IPM gave 85% efficacy.



   There were no significant differences in efficacy at eight weeks between zeta-cypermethrin in wool grease and deltamethrin and alphacypermethrin in the commercial pourons tested ; however, zeta-cypermethrin (2 mg/kg) in wool grease gave better lice control than the commercial pour-ons for the first 5 weeks. Spinosad in IPM gave better control of sheep lice than spinosad in the wool grease gave at comparable dose rates.



   Example 3 : Evaluation of spinosad in a variety
 of carriers as a pour-on formulation for
 the control of Bovicola ovis on sheep.



   The aim of this study was to select the most efficacious of a range of eight formulations that were selected on the basis of safety, physical properties, efficacy, cost and theories of dermal insecticide spread.



   Each formulation was prepared to provide spinosad at a dose of 0. 4 mg/kg and applied at a rate of 1 mL/5 kg of body weight. Groups of lousy sheep housed indoors (6 sheep per group) were treated with spinosad formulated in these carriers : IPM containing 0.   6%    oleic acid (IPM), 
GTCC/IPM/COI (70 : 15 : 15), OP/IPM/OSU (70 : 15 : 15), TPM/WG/GTCC (60 : 20 : 20), OP/IPM (80 : 20), TPM/OSU (80 : 20), GTCC/OP (80 : 20) and an aqueous formulation.



   Five of the formulations, IPM, GTCC/IPM/COI,
OP/IPM/OSU, TPM/WG/GTCC and the aqueous formulation, all gave about 90% efficacy by the end of the study. OP/IPM was inferior to the others and was eliminated. TPM/OSU and
GTCC/OP were also somewhat less effective than the rest.



  The TPM/WG/OSU formulation was eliminated because WGcontaining formulations cause dirty discolouration of the wool in sheep run outdoors. IPM alone was not a practical formulation due to skin irritation.



   The best formulations, in order of cost from cheapest to most expensive, were : aqueous, OP/IPM/OSU and
GTCC/IPM/COI.



   Example 4 : Determination of the therapeutic
 efficacy and dose titration of spinosad
 in a pour-on formulation for the control
 of Bovicola ovis on sheep
 This study was carried out to select the dose of spinosad required to eradicate sheep body lice when applied as a pour-on in OP/IPM/OSU (70 : 15 : 15) containing   5%    oleic acid, and to compare the efficacy of spinosad at 0. 4 mg/kg in a suspension concentrate (SC) formulation applied as a pour-on with that of the pour-on organic solvent formulation. The spinosad formulations were applied at 1 mL/5kg and at 0, 0. 2, 0. 4, 0. 8, 1. 6 and 3. 2 mg/kg to 6 groups of 6 recently shorn sheep that were housed outdoors for 6 weeks.



   The results observed with the   OP/IPM/OSU/oleic    acid formulation are summarized in Table 2 : 
 Table 2 : Comparison of Efficacy of Various Dosage
 Levels of Spinosad Administered in an
 OP/IPM/OSU Pour-On Formulation
 Spinosad Dosage Efficacy   (%)    at
 (mg/kg) Da y 41
 0. 2 37
 0. 4 46
 0. 8 78
 1. 6 37
 3. 2 93
 In the SC formulation spinosad at 0. 4 mg/kg gave   65%    efficacy.



   Example 5 : Diffusion of   14C-zeta-cypermethrin   
 on sheep skin in a variety of carriers
 This study compared the amount and rate of diffusion of   14C-labelled zeta-cypermethrin    from the dorsal midline of sheep, when applied in wool grease, in an aqueous formulation and in a range of test carriers.



   Five formulations containing 10 mg/mL zetacypermethrin spiked with 100 Ci   [14C]    zeta-cypermethrin were prepared using the following carriers : wool grease (1), 100 g/L emulsifiable concentrate (EC) diluted 1 : 10 in water (2), IPM (3), OS (4), and GTCC (5).



   Each formulation was applied to the backline of three sheep at 1 mL/5kg body weight. Wool was collected from three 12 x   12-mm    squares chosen at random, along meridian lines drawn 2, 7. 5 and 15 cm down the side of each sheep from the backline. The wool samples were collected at 1, 2, 4, 8, 11 and 14 days after treatment, and each day's samples were pooled. The clipped areas were also swabbed.



  At day 14 after treatment, the wool at the site of application was collected and back and perirenal fat samples were collected. The quantity of zeta-cypermethrin in each sample was measured by liquid scintillation counting.



   At most meridians and at most times IPM gave the greatest spread of zeta-cypermethrin and wool grease the least. In the wool-grease formulations, the amount of zetacypermethrin present continued to increase with time only at the 2-cm meridian. The quantity of zeta-cypermethrin measured at all meridians increased with time following IPM.



  OS and GTCC gave modest spread, but the data did not allow determination of whether spread was continuing. The EC gave little spread, and movement of zeta-cypermethrin reached a plateau after 2 weeks. IPM caused a severe scabbing/crusting of the skin at the site of application.



   The experiment was concluded at 2 weeks posttreatment. Wool grease and the EC formulation gave poor spread, GTCC and OS gave better spread and IPM gave the best spread of zeta-cypermethrin of the vehicles tested.



   Example 6 : Evaluation of   zeta-cypermethrin    in
 a variety of carriers, as a pour-on
 formulation for the control of Bovicola
 ovis on sheep
 These studies were devised to determine the efficacy of zeta-cypermethrin (at 2 mg/kg of body weight) in several nonaqueous formulations, and a commercial formulation of deltamethrin, on sheep infested with a severely synthetic pyrethroid (SP) resistant (Hartley) strain and a moderately SP resistant (Claremont) strain of
Bovicola ovis. Some additional studies were undertaken with susceptible and slightly resistant lice to determine whether zeta-cypermethrin was able to kill lice under optimum conditions.



   The nonaqueous formulations tested were : OP/IPM (80 : 20) ; 2) GTCC/OP (80 : 20) ; 3) WG/C8-10 methyl esters/OP/GTCC [20% WG,   20%    esters and   60%    of OP/GTCC (80 : 20)] ; 4)   20%    WG and   80%    GTCC/OP (80 : 20) ; and 5)   85%   
GTCC/OP (80 : 20) and   15%    WG.



   Against lice with high and moderate levels of resistance to the SPs, no treatment gave satisfactory lice control. Increasing the volume of formulation applied, but keeping the dose constant, led to a slight increase in efficacy against the moderately resistant strain. Zetacypermethrin eradicated lice on sheep infested with the susceptible strain and gave excellent control against a mildly resistant strain.



   None of the formulations was significantly superior. The liquid wool-grease-containing formulations produced a very unsightly dirty mark in the wool along the treated area that would not be acceptable to farmers.



   The OP/IPM or   GTCC/OP    formulations appeared to provide a good starting point to find a useful zetacypermethrin sheep pour-on formulation.



   Example 7 : Evaluation of zeta-cypermethrin in
 a variety of carriers, as a pour-on
 formulation for the control of Bovicola
 ovis on sheep
 Example 6 revealed that zeta-cypermethrin at 2 mg/kg did not give adequate control against SP-resistant strains of Bovicola ovis, but did control SP-susceptible lice. This study evaluated various zeta-cypermethrin formulations for their effectiveness in controlling sheep body lice.



   Five formulations of zeta-cypermethrin (Treatments 3-9) were compared to a commercial suspension concentrate (SC) formulation of alphacypermethrin for efficacy to treat moderately SP-resistant lice in sheep. The formulations were tested as follows :
 Treatment Carrier Dosage   (mg/kg) a   
 1 Control 0
 2 Alphacypermethrin SC 4
 3 OP/IPM (80 : 20) 2    4"4   
 5 GTCC/OP (80 : 20) 2    6"4   
 7 TPM/WG/GTCC (60 : 20 : 20) 4
 8 OP/IPM/OSU (70 : 15 : 15) 4
 9 TPM/benzyl alcohol (80 : 20) 4   a The    2 mg/kg dosage was applied at 10 g/L ; and the 4mg/kg dosage was applied at 20 g/L.



   None of the zeta-cypermethrin formulations tested eradicated lice. The TPM/benzyl alcohol formulation gave the lowest counts following treatment. The OP/IPM at 2 mg/kg and OP/IPM/OSU at 4 mg/kg formulations gave the next best control. The OP/IPM and GTCC/OP formulations at 4 mg/kg were similar in efficacy to that of the alphacypermethrin suspension concentrate formulation.



   These results indicated that the TPM/benzyl alcohol or OP/IPM/OSU formulations delivering 4 mg/kg zetacypermethrin would control strains of lice exhibiting zero to low resistance to SPs. Since zeta-cypermethrin at 2 mg/kg in an inferior formulation (Example 6) eliminated susceptible lice, a TPM/benzyl alcohol or OP/IPM/OSU formulation delivering 4 mg/kg zeta-cypermethrin should give excellent control of SP-susceptible lice.



   Example 8 : Small scale trial to evaluate
 spinosad in a variety of carriers, as a
 pour-on formulation for the control of
 Bovicola ovis on sheep
 In Example 3, lousy sheep housed indoors were treated with 0. 4 mg/kg spinosad formulated in OP/IPM/OSU and lice numbers declined by   90%.    When a similar formulation containing   5%    oleic was applied to sheep housed outdoors, efficacy was only 46% (Example 4). This experiment explored the effects of an outdoor environment and oleic acid on the efficacy of a spinosad-containing pour-on formulation against lice.



   Spinosad was formulated at 2 g/L in OP/IPM/OSU (70 : 15 : 15). Each formulation was applied at 1 mL/5kg (or 0. 4 mg/kg) to groups of two louse-infested sheep. There was an outdoor untreated control group. One indoor and one outdoor group were treated with OP/IPM/OSU as in Example 3.



  Another outdoor group was treated with OP/IPM/OSU plus   5%    oleic acid as in Example 4. A fourth outdoor group was treated with OP/IPM/OSU plus   5%    oleic acid plus the antioxidant BHT.



   The indoor treated sheep had a   77%    percent reduction in lice numbers after 28 days ; this result was similar to the effect observed in Example 3. The outdoor untreated group had 0% reduction in counts. Both outdoor groups treated with oleic acid-containing formulations had   40-50%    reduction in counts, which was similar to the efficacy seen in Example 4. BHT had no effect on efficacy.



   Example 9 : Evaluation of spinosad in a variety
 of carriers, as a pour-on formulation 
 for the control of Bovicola ovis on
 sheep.



   This study assessed the effectiveness of spinosad in an OP/IPM/OSU formulation, a TPM/benzyl alcohol formulation, a suspension concentrate and two other aqueous formulations to control lice outdoors. Another purpose was to confirm that outdoor conditions reduce the efficacy of any formulation, as compared to indoor conditions. The study also assessed the efficacy of UV absorbers/blockers on outdoor efficacy. Merino sheep were used, and the study ran for 6 weeks.



   All formulations contained spinosad at 2 mg/kg   (lmL/5kg    body weight). Each of the five formulations was given with a UV blocker present. In addition, the
OP/IPM/OSU formulation without UV blocker was tested indoors and outdoors.



   The nonaqueous formulations contained 1% spinosad and were formulated and tested as follows :
Group Carrier Ratio
 Housed
 2 OP/IPM/OSU 70 : 15 : 15
 indoors
 3 OP/IPM/OSU/zinc oxide/IPP/BHT
 63 : 13 : 13 : 6. 6 : 2. 9 : 1 outdoors
 4 OP/IPM/OSU 70 : 15 : 15
 outdoors
 5 TPM/benzyl alcohol/zinc oxide/IPP/BHT
 73 : 18 : 6. 6 : 2. 9 : 1 outdoors
 The OP/IPM/OSU formulation delivering 2 mg/kg spinosad gave 99.   96%    efficacy indoors ; this result was significantly superior to that seen with the same formulation outdoors with or without a UV blocker. In the groups housed outdoors, each formulation was similar in effectiveness, although the OP/IPM/OSU formulation was the most effective. UV blockers did not significantly increase efficacy.



   Example 10 : Evaluation of a variety of pour-on
 carriers with ivermectin and
 hexaflumuron for the control of Bovicola
 ovis on sheep
 Several previous experiments (Examples 3, 4, 6, 8 and 9) have shown that an OP/IPM/OSU (70 : 15 : 15) formulation is both safe for sheep skins and an effective vehicle to deliver zeta-cypermethrin and spinosad to control lice in sheep. Similarly, carriers based on TPM, such as TPM/benzyl alcohol (80 : 20) are safe and effective. The aim of this study was to demonstrate that these formulations could deliver other classes of ectoparasticides, such as macrocyclic lactones (ivermectin) and insect growth regulators (hexaflumuron).



   In the study, groups of 4 Merino sheep, housed indoors, were treated with ivermectin (40 mg/sheep) or hexaflumuron (600 mg/sheep) in OP/IPM/OSU (70 : 15 : 15) or
TPM/benzyl alcohol (80 : 20). Sheep were treated with 20   mL    of formulation applied to the backline. Six sheep were left untreated as controls. Lice were counted every 2 weeks for 12 weeks.



   Tables 3 and 4 summarize the results of these studies.



   Table 3 : Lice counts in sheep at day   0    and 14,
 28, 42, 56 and 85 days after treatment
 with ivermectina 
EMI28.1     


Group <SEP> Day <SEP> 0 <SEP> Day <SEP> Day <SEP> Day <SEP> Day <SEP> Day
<tb>  <SEP> 14 <SEP> 28 <SEP> 42 <SEP> 56 <SEP> 85
<tb> Control
<tb> Mean <SEP> 618. <SEP> 7 <SEP> 540. <SEP> 0 <SEP> 463. <SEP> 7 <SEP> 611. <SEP> 0 <SEP> 562. <SEP> 8 <SEP> 533. <SEP> 0
<tb> Geo <SEP> Mean <SEP> 608. <SEP> 8 <SEP> 518. <SEP> 4 <SEP> 414. <SEP> 5 <SEP> 586. <SEP> 5 <SEP> 513. <SEP> 8 <SEP> 461. <SEP> 4
<tb> OP/IPM/OSUP
<tb> Mean <SEP> 706. <SEP> 0 <SEP> 2. <SEP> 3 <SEP> 0. <SEP> 5 <SEP> 0 <SEP> 0 <SEP> 0
<tb> Geo <SEP> Mean <SEP> 698. <SEP> 4 <SEP> 1. <SEP> 3 <SEP> 0. <SEP> 3
<tb> TPM/Benzyl
<tb> Alcohol  <SEP> 606. <SEP> 0 <SEP> 9. <SEP> 5 <SEP> 4. <SEP> 3 <SEP> 0. <SEP> 5 <SEP> 0. <SEP> 5 <SEP> 0
<tb> Mean <SEP> 564. <SEP> 9 <SEP> 6.

   <SEP> 3 <SEP> 1. <SEP> 9 <SEP> 0. <SEP> 4 <SEP> 0. <SEP> 3
<tb> Geo <SEP> Mean
<tb> 
 40 mg/sheep
 b 70 : 15 : 15   80    : 20
 Table 4 : Lice Counts in sheep at day   0    and 14,
 28, 42, 56 and 85 days after treatment
 with   hexaflumarona   
EMI28.2     


Group <SEP> Day <SEP> 0 <SEP> Day <SEP> Day <SEP> Day <SEP> Day <SEP> Day
<tb>  <SEP> 14 <SEP> 28 <SEP> 42 <SEP> 56 <SEP> 85
<tb> Control
<tb> Mean <SEP> 618. <SEP> 7 <SEP> 540. <SEP> 0 <SEP> 463. <SEP> 7 <SEP> 611. <SEP> 0 <SEP> 562. <SEP> 8 <SEP> 533. <SEP> 0
<tb> Geo <SEP> Mean <SEP> 608. <SEP> 8 <SEP> 518. <SEP> 4 <SEP> 414. <SEP> 5 <SEP> 586. <SEP> 5 <SEP> 513. <SEP> 8 <SEP> 461. <SEP> 4
<tb> OP/IPM/OSU"
<tb> Mean <SEP> 690. <SEP> 0 <SEP> 86. <SEP> 3 <SEP> 37. <SEP> 8 <SEP> 14. <SEP> 5 <SEP> 6. <SEP> 0 <SEP> 2. <SEP> 3
<tb> Geo <SEP> Mean <SEP> 683.

   <SEP> 1 <SEP> 39. <SEP> 0 <SEP> 8. <SEP> 6 <SEP> 3. <SEP> 3 <SEP> 2. <SEP> 9 <SEP> 1. <SEP> 1
<tb>  
EMI29.1     


TPM <SEP> Benzyl
<tb> AlcoholC <SEP> 672. <SEP> 3 <SEP> 324. <SEP> 5 <SEP> 110. <SEP> 8 <SEP> 46. <SEP> 8 <SEP> 44. <SEP> 3 <SEP> 16. <SEP> 8
<tb> Mean <SEP> 656. <SEP> 7 <SEP> 266. <SEP> 9 <SEP> 91. <SEP> 0 <SEP> 31. <SEP> 7 <SEP> 32. <SEP> 4 <SEP> 10. <SEP> 3
<tb> Geo <SEP> Mean
<tb> 
 a 600 mg/sheep
 70 : 15 : 15   c 80    : 20
 Example 11 : Evaluation of spinosad in two pour
 on formulations and ivermectin as a
 pour-on for the control of Bovicola ovis
 on sheep housed outdoors
 This study evaluated the efficacy of spinosad to eradicate lice in sheep when administered in two pour-on vehicles. It also determined the effect of increasing dose or volume on efficacy and whether the incorporation of UV blockers/absorbers increases efficacy.

   The study further evaluated the efficacy of ivermectin to eradicate lice when administered in a pour-on formulation to sheep housed outdoors.



   Spinosad was administered in OP/IPM/OSU (70 : 15 : 15) at 2 and 10 mg spinosad/kg body weight, with and without UV blockers, and applied at 2 mL/5kg of body weight.



  Ivermectin was administered at 40 mg/sheep in 20 mL of
OP/IPM/OSU (70 : 15 :   15).    Spinosad was also administered in an aqueous formulation at 2, 10 and 50 mg/kg without UV blockers and applied at 1 mL/5kg. In addition, the 2 mg/kg formulation was applied at 1 mL/kg. All treatments were applied as a broad band along the backline. The study ran for 6 weeks. 



   These results were observed :
 A) Spinosad in OP/IPM/OSU : at 10 mg/kg, with or without UV blockers, it eradicated lice outdoors ; at 2 mg/kg, it gave 85 to   98%    efficacy.



   B) Spinosad in aqueous formulation : at 50 mg/kg, it eradicated lice ; at 10 mg/kg, it gave   98%    efficacy ; at 2 mg/kg, it gave 74% efficacy when applied at 1   mL/5kg    and   61%    efficacy when applied at 1 mL/kg.



   C) Ivermectin in OP/IPM/OSU : at 40 mg/sheep, it gave 96% efficacy.



   D) The use of UV blockers or increasing the volume applied did not increase efficacy.



   Example 12 : Physical characteristics of various
 formulations.



   The physical characteristics of various individual solvents and solvent combinations were determined. Table 5 summarizes the results of these determinations.



   Table 5 : Summary of formulation properties and
 freezing points
EMI30.1     


 <SEP> Vehicle <SEP> Physical <SEP> Properties
<tb> IPM <SEP> Freeze-2 <SEP> to-6wC, <SEP> penetrates <SEP> +
<tb>  <SEP> spreads, <SEP> modifies <SEP> heavy <SEP> oils
<tb> GTCC <SEP> Freeze-5 <SEP> to-13wC, <SEP> safe,
<tb>  <SEP> solvent/diluent
<tb> OP <SEP> or <SEP> OS <SEP> Freeze <SEP> 3 <SEP> to-4¯C, <SEP> spreads, <SEP> lubricant
<tb> OSU <SEP> Freeze <SEP> 0 <SEP> to <SEP> 15¯C, <SEP> good <SEP> spreader, <SEP> wets
<tb> COI <SEP> Freeze <SEP> OC, <SEP> water <SEP> resistant, <SEP> good
<tb>  <SEP> wetter <SEP> + <SEP> spreader
<tb> TPM <SEP> Freezes <SEP>  -15C
<tb>  
EMI31.1     


<tb> OP/IPM <SEP> Freezes-4 <SEP> to <SEP> - <SEP> 7@C
<tb> (80 <SEP> : <SEP> 20)
<tb> OP/OSUFreezes-7 <SEP> to-10'C
<tb> (80 <SEP> : <SEP> 20)
<tb> GTCC/IPM <SEP> Freezes <SEP>  < -10wC
<tb> (80 <SEP> :

   <SEP> 20)
<tb> TPM/2-octyl <SEP> Freezes <SEP> -15@C
<tb> dodecanol
<tb> (80 <SEP> : <SEP> 20)
<tb> TPM/diaceton <SEP> Freezes <SEP>  < -15@C
<tb> e <SEP> alcohol
<tb>  <SEP> (80 <SEP> : <SEP> 20)
<tb> 
  


Claims

CLAIMS 1. A non-irritant topically acceptable carrier selected from the group consisting of : a) i) at least one of tripropylene glycol methyl ether and dipropylene glycol methyl ether, and ii) at least one of alcohol, wool grease and propylene glycol, wherein (i) is present in an amount of at least about 60% wt of the carrier ; b) i) at least one of octyl palmitate, octyl stearate and glyceryl tri caprylate/caprate, and ii) at least one of dioctyl succinate, isopropyl myristate, cetearyl octanoate, propylene glycol 2 myristyl ether propionate, isopropyl palmitate, isopropyl laurate, isocetyl stearate, oleic acid and methyl oleate, and optionally including iii) at least one of alcohol, wool grease and propylene glycol, wherein (ii) is present in an amount of up to about 40% wt of the carrier ;
and c) i) at least one of octyl palmitate, octyl stearate and glyceryl tri caprylate/caprate, and ii) at least one of alcohol, wool grease and propylene glycol, wherein (i) is present in an amount of at least about 60% wt of the carrier.
2. A carrier of Claim 1 wherein the carrier is selected from (a), (i) is tripropylene glycol methyl ether, and (ii) is an alcohol selected from benzyl alcohol and diacetone alcohol.
3. A carrier of Claim 2 wherein the ratio of tripropylene glycol methyl ether : alcohol is in the range of 60-95 : 40-5.
4. A carrier of Claim 1 wherein the carrier is selected from (b).
5. A carrier of Claim 4 wherein the ratio of tripropylene glycol methyl ether : alcohol is 80 : 20.
6. A carrier of Claim 1 wherein the carrier is selected from (b).
7. A carrier of Claim 6 wherein (i) is octyl palmitate or octyl stearate.
8. A carrier of Claim 6 or 7 wherein (ii) comprises isopropyl myristate and dioctyl succinate.
9. A carrier of Claim 8 wherein (i) is octyl palmitate and the ratio of octyl palmitate : isopropyl myristate : dioctyl succinate is 60-90 : 20-5 : 20-5.
10. A carrier of Claim 9 wherein the ratio is 70 : 15 : 15.
11. A carrier of Claim 6 wherein (i) is glyceryl tri caprylate/caprate and (ii) comprises isopropyl myristate and a blend of isopropyl myristate and cetearyl octanoate.
12. A carrier of Claim 11 wherein the ratio of glyceryl tri caprylate/caprate : isopropyl myristate : blend of. isopropyl myristate and cetearyl octanoate is in a range of 60-90 : 20-5 : 20-5.
13. A carrier of Claim 12 wherein the ratio is 70 : 15 : 15.
14. A carrier of Claim 6 which further includes (iii) at least one of alcohol, wool grease and propylene glycol.
15. A non-irritant pour-on formulation for control of an external parasite in an animal of agricultural worth, said formulation including an ectoparasiticidal amount of an active agent and a carrier of any one of Claims 1-14.
16. A formulation of Claim 15 wherein the active agent is selected from the group consisting of spinosyns, synthetic pyrethroids, macrocyclic lactones, diamidides (formamidines), thiazoles, dursban, carbamates, benzimidazoles, fipronil, imidacloprid, triazines, waterinsoluble organo-phosphate compounds, propoxur, cabaryl, maldison, dimethoate, rotenone, piperonyl butoxide, Bacillus thuringensis, ronnel, crufomate, benzoylphenylureas and other insect growth regulators, insect development inhibitors, or juvenile insect hormone analogues.
17. A formulation of Claim 16 wherein the active agent is a spinosyn, and the spinosyn is spinosad.
18. A formulation of Claim 16 wherein the active agent is a synthetic pyrethroid, and the pyrethroid is a cypermethrin.
19. A formulation of Claim 16 wherein the active agent is a macrocyclic lactone, and the macrocyclic lactone is ivermectin.
20. A formulation of Claim 16 wherein the active agent is an insect growth regulator, and the insect growth regulator is hexaflumuron.
21. A formulation of any one of Claims 15-20 wherein the animal of agricultural worth is a sheep.
22. A method of controlling an external parasite in an animal of agricultural worth, said method including topically applying an ectoparasiticidally effective volume of a pour-on formulation according to any one of Claims 15-21.
23. A carrier as claimed in any one of Claims 1-14 for use in a non-irritant pour-on formulation for controlling an external parasite in an animal of agricultural worth wherein the formulation also includes an effective amount of an ectoparasiticidal agent.
24. A carrier as claimed in any one of Claims 1-14 for use in therapy.
PCT/US2000/030143 1999-12-02 2000-11-17 Pour-on formulations WO2001040446A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU19148/01A AU775911B2 (en) 1999-12-02 2000-11-17 Pour-on formulations
DK00982076T DK1237408T3 (en) 1999-12-02 2000-11-17 Pour-on formulations
DE60008422T DE60008422T2 (en) 1999-12-02 2000-11-17 POUR-ON FORMULATIONS
EP00982076A EP1237408B1 (en) 1999-12-02 2000-11-17 Pour-on formulations
AT00982076T ATE259590T1 (en) 1999-12-02 2000-11-17 POUR-ON FORMULATIONS
US10/130,315 US6955818B1 (en) 1999-12-02 2000-11-17 Pour-on formulations
NZ518030A NZ518030A (en) 1999-12-02 2000-11-17 Pour-on formulations containing a spinosyn in a carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ4416A AUPQ441699A0 (en) 1999-12-02 1999-12-02 Pour-on formulations

Publications (3)

Publication Number Publication Date
WO2001040446A1 true WO2001040446A1 (en) 2001-06-07
WO2001040446A8 WO2001040446A8 (en) 2001-07-05
WO2001040446A3 WO2001040446A3 (en) 2002-01-17

Family

ID=3818558

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030143 WO2001040446A1 (en) 1999-12-02 2000-11-17 Pour-on formulations

Country Status (14)

Country Link
US (1) US6955818B1 (en)
EP (1) EP1237408B1 (en)
AR (1) AR027890A1 (en)
AT (1) ATE259590T1 (en)
AU (2) AUPQ441699A0 (en)
CO (1) CO5271707A1 (en)
DE (1) DE60008422T2 (en)
DK (1) DK1237408T3 (en)
ES (1) ES2214339T3 (en)
NZ (1) NZ518030A (en)
PT (1) PT1237408E (en)
TR (1) TR200400599T4 (en)
WO (1) WO2001040446A1 (en)
ZA (1) ZA200202537B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002050042A2 (en) * 2000-12-21 2002-06-27 Bayer Aktiengesellschaft Use of pyrazol oximes as parasiticidal agents
US6664237B1 (en) 1999-08-12 2003-12-16 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
EP1499184A2 (en) * 2002-04-29 2005-01-26 Piedmont Pharmaceuticals, LLC Methods and compositions for treating ectoparasite infestation
US6927210B1 (en) 1999-08-12 2005-08-09 Eli Lilly And Company Ectoparasiticidal aqueous suspension formulations of spinosyns
US6933318B1 (en) 1999-08-12 2005-08-23 Eli Lilly And Company Topical organic ectoparasiticidal formulations
WO2009152597A2 (en) * 2008-06-17 2009-12-23 Sespo Indústria E Comércio Ltda Topical use composition for combatting ectoparasites in dogs and cats
WO2009027506A3 (en) * 2007-08-30 2010-02-18 Intervet International B.V. Local topical administration formulations containing fipronil
WO2010026370A1 (en) * 2008-09-05 2010-03-11 Norbrook Laboratories Limited A topical ectoparasiticide composition
US7772194B2 (en) 2001-09-17 2010-08-10 Eli Lilly And Company Pesticidal formulations
EP2271210A1 (en) 2008-04-02 2011-01-12 Bayer Cropscience LP Synergistic pesticide compositions
US8404735B2 (en) 2009-03-18 2013-03-26 Omnipharm Limited Parasiticidal formulation
EP2961397A4 (en) * 2013-02-27 2016-11-02 Laurie Robert Batt Transdermal formulations
EP3424321A1 (en) 2017-07-06 2019-01-09 Ferrer Internacional, S.A. Compounds for treating ectoparasite infestation

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906128B2 (en) * 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
WO2004043446A2 (en) * 2002-11-14 2004-05-27 Novartis Ag Combination product for controlling insect pests
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
WO2006007630A1 (en) * 2004-07-22 2006-01-26 Jurox Pty Ltd Aqueous insecticidal/parasiticide formulation
PE20060785A1 (en) * 2004-10-08 2006-09-19 Wyeth Corp AMITRAZ COMPOSITIONS
TWI368505B (en) * 2005-05-24 2012-07-21 Wyeth Corp Versatile high load concentrate compositions for control of ecto-parasites
US20080112993A1 (en) * 2005-05-24 2008-05-15 Wyeth High-dose, long-lasting ectoparasiticide for extended control
TW200846029A (en) * 2007-02-09 2008-12-01 Wyeth Corp High dose, long-acting ectoparasiticide for extended control
TW201041508A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
TW201041510A (en) * 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
TW201041507A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity and methods for preparing same
TW201041509A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
US20160309708A1 (en) 2013-12-11 2016-10-27 Oxiteno S.A. Indústria E Comércio Polycarboxylic acid ester alkyl derived from branched and straight alcohol of plant origin, and use of an alkyl ester in agrochemical formulations
WO2015161224A1 (en) * 2014-04-17 2015-10-22 Merial, Inc. Use of malononitrile compounds for protecting animals from parasites

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045424A1 (en) * 1980-08-02 1982-02-10 Bayer Ag Pour-on formulations active against ticks
EP0069269A2 (en) * 1981-07-01 1983-01-12 Bayer Ag Ectoparasiticidal spray formulation
GB2135886A (en) * 1983-02-22 1984-09-12 Wellcome Found Pesticidal pour-on formulations
DE3531920A1 (en) * 1985-09-07 1987-03-12 Bayer Ag Method for combating ectoparasites in goats
EP0496316A1 (en) * 1991-01-19 1992-07-29 Hoechst Aktiengesellschaft Pour-on formulation for application of anthelminthics
WO1994026113A2 (en) * 1993-05-10 1994-11-24 Merck & Co., Inc. Pour-on formulations containinng polymeric material, glycols and glycerides
WO1997012521A1 (en) * 1995-09-29 1997-04-10 Rhone Merieux Antiparasitic composition for treating and protecting pets
WO1997036486A1 (en) * 1996-03-29 1997-10-09 Merial Solution for direct application on the skin for controlling cattle and sheep parasites
GB2317564A (en) * 1996-03-29 1998-04-01 Merial Sas Insecticidal combination effective against fleas on mammals,particularly cats and dogs
WO2000030449A1 (en) * 1998-11-19 2000-06-02 Pfizer Limited Antiparasitic formulations
WO2001012156A1 (en) * 1999-08-12 2001-02-22 Eli Lilly And Company Topical organic ectoparasiticidal formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362634A (en) 1989-10-30 1994-11-08 Dowelanco Process for producing A83543 compounds
OA09249A (en) 1988-12-19 1992-06-30 Lilly Co Eli Compounds of macrolides.
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5227295A (en) 1991-11-08 1993-07-13 Dowelanco Process for isolating A83543 and its components
US5202242A (en) 1991-11-08 1993-04-13 Dowelanco A83543 compounds and processes for production thereof
US5539089A (en) 1991-11-08 1996-07-23 Dowelanco A83543 aglycones and pseudoglycones
US5591606A (en) 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
EP0688332B1 (en) 1993-03-12 1997-03-26 Dowelanco New a83543 compounds and process for production thereof
CN1130369C (en) 1995-06-14 2003-12-10 道农业科学公司 Synthetic modification to spinosyn compounds
US5695776A (en) 1996-03-12 1997-12-09 Fmc Corporation Termite bait apparatus having grooves
US6010710A (en) 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
US6001981A (en) 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
FR2756177B1 (en) * 1996-11-28 1999-01-29 Oreal AQUEOUS DISPERSION OF DEHYDRATION RESISTANT VESICLES
US5880076A (en) * 1997-08-04 1999-03-09 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycacarbamate and glycaurea compounds
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
NZ509118A (en) * 1998-07-02 2003-02-28 Lilly Co Eli Formulations for controlling human lice containing spinosyn
WO2000060940A1 (en) 1999-04-12 2000-10-19 Dow Agrosciences Llc Aqueous dispersions of agricultural chemicals
IL147827A0 (en) 1999-08-12 2002-08-14 Lilly Co Eli Ectoparasiticidal aqueous suspension formulations of spinosyns
AU6605300A (en) 1999-08-12 2001-03-13 Eli Lilly And Company Control of ectoparasites using spinosyns
IL147828A0 (en) 1999-08-12 2002-08-14 Lilly Co Eli Oral treatment of companion animals with ectoparasiticidal spinosyns
WO2001011962A1 (en) 1999-08-12 2001-02-22 Eli Lilly And Company Topical treatment for insect pests in companion animals
EP1212337B1 (en) 1999-09-13 2004-10-20 Dow AgroSciences LLC Pesticidal macrolides

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045424A1 (en) * 1980-08-02 1982-02-10 Bayer Ag Pour-on formulations active against ticks
EP0069269A2 (en) * 1981-07-01 1983-01-12 Bayer Ag Ectoparasiticidal spray formulation
GB2135886A (en) * 1983-02-22 1984-09-12 Wellcome Found Pesticidal pour-on formulations
DE3531920A1 (en) * 1985-09-07 1987-03-12 Bayer Ag Method for combating ectoparasites in goats
EP0496316A1 (en) * 1991-01-19 1992-07-29 Hoechst Aktiengesellschaft Pour-on formulation for application of anthelminthics
WO1994026113A2 (en) * 1993-05-10 1994-11-24 Merck & Co., Inc. Pour-on formulations containinng polymeric material, glycols and glycerides
WO1997012521A1 (en) * 1995-09-29 1997-04-10 Rhone Merieux Antiparasitic composition for treating and protecting pets
WO1997036486A1 (en) * 1996-03-29 1997-10-09 Merial Solution for direct application on the skin for controlling cattle and sheep parasites
GB2317564A (en) * 1996-03-29 1998-04-01 Merial Sas Insecticidal combination effective against fleas on mammals,particularly cats and dogs
WO2000030449A1 (en) * 1998-11-19 2000-06-02 Pfizer Limited Antiparasitic formulations
WO2001012156A1 (en) * 1999-08-12 2001-02-22 Eli Lilly And Company Topical organic ectoparasiticidal formulations

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664237B1 (en) 1999-08-12 2003-12-16 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
US6927210B1 (en) 1999-08-12 2005-08-09 Eli Lilly And Company Ectoparasiticidal aqueous suspension formulations of spinosyns
US6933318B1 (en) 1999-08-12 2005-08-23 Eli Lilly And Company Topical organic ectoparasiticidal formulations
WO2002050042A3 (en) * 2000-12-21 2002-11-28 Bayer Ag Use of pyrazol oximes as parasiticidal agents
WO2002050042A2 (en) * 2000-12-21 2002-06-27 Bayer Aktiengesellschaft Use of pyrazol oximes as parasiticidal agents
EP2347654B1 (en) * 2001-09-17 2019-02-27 Elanco US Inc. Formulation for controlling lice or ticks in catlle
US8048861B2 (en) 2001-09-17 2011-11-01 Eli Lilly And Company Pesticidal formulations
EP3488698A1 (en) * 2001-09-17 2019-05-29 Elanco US Inc. Pesticidal formulations
US7772194B2 (en) 2001-09-17 2010-08-10 Eli Lilly And Company Pesticidal formulations
EP1499184A2 (en) * 2002-04-29 2005-01-26 Piedmont Pharmaceuticals, LLC Methods and compositions for treating ectoparasite infestation
US8178116B2 (en) 2002-04-29 2012-05-15 Piedmont Pharmaceuticals, Llc Methods and compositions for treating ectoparasite infestation
EP1499184A4 (en) * 2002-04-29 2007-04-25 Piedmont Pharmaceuticals Llc Methods and compositions for treating ectoparasite infestation
EP2286663A3 (en) * 2002-04-29 2011-06-15 Piedmont Pharmaceuticals, LLC Methods and compositions for treating ectoparasite infestation
AU2008203312B2 (en) * 2002-04-29 2012-04-19 Nuvo Pharmaceuticals (Ireland) Designated Activity Company Methods and compositions for treating ectoparasite infestation
WO2009027506A3 (en) * 2007-08-30 2010-02-18 Intervet International B.V. Local topical administration formulations containing fipronil
EP2271210A1 (en) 2008-04-02 2011-01-12 Bayer Cropscience LP Synergistic pesticide compositions
US9028856B2 (en) 2008-04-02 2015-05-12 Bayer Cropscience Lp Synergistic pesticide compositions
WO2009152597A3 (en) * 2008-06-17 2010-03-04 Sespo Indústria E Comércio Ltda Topical use composition for combatting ectoparasites in dogs and cats
WO2009152597A2 (en) * 2008-06-17 2009-12-23 Sespo Indústria E Comércio Ltda Topical use composition for combatting ectoparasites in dogs and cats
WO2010026370A1 (en) * 2008-09-05 2010-03-11 Norbrook Laboratories Limited A topical ectoparasiticide composition
US8404735B2 (en) 2009-03-18 2013-03-26 Omnipharm Limited Parasiticidal formulation
US8580837B2 (en) 2009-03-18 2013-11-12 Fidopharm, Inc. Parasiticidal formulation
US8829038B2 (en) 2009-03-18 2014-09-09 Velcera, Inc. Parasiticidal formulation
EP2961397A4 (en) * 2013-02-27 2016-11-02 Laurie Robert Batt Transdermal formulations
EP3954363A1 (en) * 2013-02-27 2022-02-16 Argenta Innovation Limited Transdermal formulations
EP3424321A1 (en) 2017-07-06 2019-01-09 Ferrer Internacional, S.A. Compounds for treating ectoparasite infestation
WO2019008116A1 (en) 2017-07-06 2019-01-10 Ferrer Internacional, S.A. Compounds, compositions thereof and methods for treating ectoparasite infestation

Also Published As

Publication number Publication date
AU775911B2 (en) 2004-08-19
DK1237408T3 (en) 2004-06-28
ZA200202537B (en) 2003-09-23
AU1914801A (en) 2001-06-12
ES2214339T3 (en) 2004-09-16
NZ518030A (en) 2004-05-28
EP1237408A2 (en) 2002-09-11
AUPQ441699A0 (en) 2000-01-06
PT1237408E (en) 2004-06-30
WO2001040446A3 (en) 2002-01-17
ATE259590T1 (en) 2004-03-15
US6955818B1 (en) 2005-10-18
TR200400599T4 (en) 2004-04-21
EP1237408B1 (en) 2004-02-18
DE60008422D1 (en) 2004-03-25
WO2001040446A8 (en) 2001-07-05
CO5271707A1 (en) 2003-04-30
AR027890A1 (en) 2003-04-16
DE60008422T2 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
EP1237408B1 (en) Pour-on formulations
US5045536A (en) Liquid formulations
AU2018202648B2 (en) Topical compositions comprising fipronil and permethrin and methods of use
CN105616406B (en) Topical localized isoxazoline formulations
US4607050A (en) Method of controlling insects and parasites with an aqueous localized pour-on formulation
EP1435786B1 (en) Pesticidal formulations
EP0120286B1 (en) Pesticidal pour-on oil formulations
NZ550771A (en) Use of neuronal sodium channel antagonists of formula Ia for the control of ectoparasites in homeothermic animals
JP2003520779A (en) Topical organic ectoparasiticide formulation
US20030161854A1 (en) Synergistic formulations
GB2135886A (en) Pesticidal pour-on formulations
Lavy et al. Aspects in controlled drug delivery for topical applications in veterinary medicine
CN108472286B (en) Medicine composition for killing animal ectoparasite and preparation method and application thereof
JP2003081719A (en) Percutaneous administration agent for controlling animal ectozoon
ZA200705786B (en) Compositions for controlling parasites comprising synergic combination of amitraz and chlorpyrifos
AU2013324536B2 (en) Veterinary pharmaceutical formulations and methods
AU2001239017B2 (en) Synergistic formulations
CN115317498A (en) Compound drop for treating parasitic and fungal skin diseases of dogs and cats and preparation method thereof
AU2005202712A1 (en) Synergistic formulations
NZ616160B2 (en) Veterinary pharmaceutical formulations and methods
AU2001239017A1 (en) Synergistic formulations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 23/2001 REPLACE "A1" BY "A2" AND UNDER "PUBLISHED" REPLACE "WITHOUT INTERNATIONAL SEARCH REPORT"

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 518030

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 19148/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 10130315

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2000982076

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000982076

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2000982076

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 518030

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 518030

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 19148/01

Country of ref document: AU